Alphabet life science subsidiary Verily recently received U.S. Food and Drug Administration (FDA) clearance for its wearable smartwatch’s EKG feature. The smartwatch—named Study Watch—is able to record, store, transfer, and display single-channel EKG rhythms.

EKG, which stands for electrocardiogram, is a paper or digital recording of the electrical signals in the heart. Verily feels that mobile health tools such as the Study Watch add a new method to understanding how the body works and how to do things like keep it healthy and help it adapt to disease. The news comes not long after the . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!